Physician profile
Randall L Dei
NPI 1487608329
$20,187.74
in general payments reported to CMS, 2019-2025
24 companies · $2,089 in 2025
The $2,089 reported for 2025 was more than what 90% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,281 · 2020: $1,744 · 2021: $3,003 · 2022: $8,986 · 2023: $1,133 · 2024: $952 · 2025: $2,089.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,021 · Travel and Lodging: $1,152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,021.36 |
| Travel and Lodging | $1,152.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Maxx Health INC | $8,366.65 | 2021-2022 | |
| Treace Medical Concepts, INC. | $5,867.23 | 2020-2025 | |
| Stryker Corporation | $1,827.46 | 2019-2025 | Ortholoc 3di, Infinity, Augment Injectable |
| Great Lakes Orthopedics | $1,361.38 | 2019 | |
| Ossio INC | $398.89 | 2023 | |
| Horizon Therapeutics Plc | $358.74 | 2019-2023 | Krystexxa |
| Smith+Nephew, INC. | $206.57 | 2021-2025 | Stravix, Oasis, Grafix Pl |
| Paragon 28, INC. | $176.15 | 2022-2023 | Portfolio |
| Orthofix Medical, INC. | $174.92 | 2024 | Physio-Stim |
| Acera Surgical, INC. | $151.67 | 2025 | Restrata Wound Matrix |
| Averitas Pharma INC. | $149.88 | 2025 | Qutenza |
| Mimedx Group, INC. | $149.69 | 2024 | |
| Wright Medical Technology, INC. | $147.27 | 2019 | |
| Nevro Corp. | $145.25 | 2022 | |
| Biotissue Holdings INC. | $121.42 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $116.06 | 2024 | Novosorb Btm |
| Zimmer Biomet Holdings, INC. | $107.35 | 2019 | |
| Globus Medical, INC. | $91.09 | 2025 | Senza |
| Solventum Corporation | $67.60 | 2024 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Pfizer INC. | $60.66 | 2019 | |
| Fusion Orthopedics USA, LLC | $56.78 | 2025 | |
| Integra Lifesciences Corporation | $47.47 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.34 | 2019 | |
| Enduromed, LLC | $18.22 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Dei listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.